Related Experiment Video
Updated: Sep 22, 2025

09:00
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
7.8K
Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles
Vinod Ravasaheb Shinde1, Neeraja Revi2, Sivasubramanian Murugappan1
1Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
Photodiagnosis and Photodynamic Therapy
|May 21, 2022
Summary
Therapeutic nanoparticles leverage the enhanced permeability and retention (EPR) effect for passive tumor targeting. This review explores EPR
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- The enhanced permeability and retention (EPR) effect is crucial for passive tumor targeting.
- Tumor microenvironments exhibit leaky vasculature and impaired lymphatic drainage, facilitating nanoparticle accumulation.
- Understanding EPR is key to developing effective nanotherapeutics.
Purpose of the Study:
- To review fundamental studies on the role of the EPR effect in passive targeting.
- To summarize therapeutic nanoformulations that utilize the EPR effect for cancer treatment.
- To highlight the application of EPR in combating neoplasia.
Main Methods:
- Review of fundamental research on the EPR effect.
- Analysis of various nanoformulation strategies for cancer therapy.
- Exploration of therapeutic modalities including chemotherapy, photodynamic therapy, and immunotherapy.
Main Results:
- The EPR effect enables preferential accumulation of nanoparticles in tumor tissues.
- Nanoformulations demonstrate significant potential in enhancing therapeutic efficacy via EPR.
- Combined therapeutic approaches show promise for improved cancer treatment outcomes.
Conclusions:
- The EPR effect is a vital phenomenon for passive nanoparticle targeting in tumors.
- Nanoformulations offer a promising platform for exploiting the EPR effect in cancer therapy.
- Further research into EPR-mediated strategies can advance cancer treatment.
Related Concept Videos
Drug Distribution: Tissue Binding
3.3K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.3K
Tissue-Drug Binding: Localization of Drugs and its Significance
180
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
180

